Jul 12, 2013, 09.16 AM IST
Prandin, known chemically as repaglinide, and its combination with the commonly prescribed type 2 diabetes drug metformin, sold as PrandiMet, had sales of about USD 200 million in 2012 for Novo.
Like this story, share it with millions of investors on M3
Sun Pharma gets FDA approval for diabetes generic drug
Prandin, known chemically as repaglinide, and its combination with the commonly prescribed type 2 diabetes drug metformin, sold as PrandiMet, had sales of about USD 200 million in 2012 for Novo.
Like this story, share it with millions of investors on M3
Sun Pharma gets FDA approval for diabetes generic drug
Prandin, known chemically as repaglinide, and its combination with the commonly prescribed type 2 diabetes drug metformin, sold as PrandiMet, had sales of about USD 200 million in 2012 for Novo.
Prandin, known chemically as repaglinide, and its combination with the commonly prescribed type 2 diabetes drug metformin, sold as PrandiMet, had sales of about USD 200 million in 2012 for Novo.
Also Read: British drug regulator recalls India's Wockhardt medicines
Sun Pharma said it would be eligible for a 180-day marketing exclusivity in the United States for the drug.
A US appeals court last month found the patent on Novo's Prandin diabetes drug in combination with metformin to be invalid, paving the way for the introduction of a generic version of the drug.
From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'
The latest earning numbers FIRST on CNBC-TV18
Anda sedang membaca artikel tentang
Sun Pharma gets FDA approval for diabetes generic drug
Dengan url
http://sehatkafein.blogspot.com/2013/07/sun-pharma-gets-fda-approval-for.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Sun Pharma gets FDA approval for diabetes generic drug
namun jangan lupa untuk meletakkan link
Sun Pharma gets FDA approval for diabetes generic drug
sebagai sumbernya
0 komentar:
Posting Komentar